ROYAL BANK OF CANADA - CARDLYTICS INC ownership

CARDLYTICS INC's ticker is and the CUSIP is 14161WAB1. A total of 12 filers reported holding CARDLYTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of CARDLYTICS INC
ValueSharesWeighting
Q2 2023$4,434,000
+1.7%
7,883,000
-24.1%
0.00%0.0%
Q1 2023$4,362,000
-1.6%
10,386,000
+0.4%
0.00%0.0%
Q4 2022$4,435,00010,345,0000.00%
Other shareholders
CARDLYTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
GUARDIAN POINT CAPITAL, LP 5,000,000$5,149,0001.88%
LINDEN ADVISORS LP 65,612,000$66,940,0000.42%
WOLVERINE ASSET MANAGEMENT LLC 38,478,000$39,110,0000.38%
Teton Advisors, Inc. 1,030,000$1,061,0000.18%
683 Capital Management, LLC 2,000,000$2,040,0000.11%
Nicholas Investment Partners, LP 1,385,000$1,401,0000.10%
GABELLI FUNDS LLC 6,920,000$7,128,0000.05%
CAPSTONE INVESTMENT ADVISORS, LLC 10,000,000$10,165,0000.03%
Citadel Advisors 98,500,000$100,325,0000.02%
GAMCO INVESTORS, INC. ET AL 300,000$309,0000.00%
View complete list of CARDLYTICS INC shareholders